Phase II Feasibility Study to Evaluate the Efficacy and Safety of Perampanel in Seizure Patients With Primary Glial Brain Tumors
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 13 Sep 2017 Status changed from recruiting to completed.
- 23 Jan 2017 Planned End Date changed from 1 Aug 2018 to 1 Aug 2020.
- 23 Jan 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Aug 2020.